sameAs
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosisIdentification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosisBortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathwayRIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosisBortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosisHistone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIPIdentification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cellsThe mechanism of necroptosis in normal and cancer cellsTargeting IAP proteins in combination with radiotherapyBetulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumorsSensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrolG-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cellscIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species productionMolecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Macrophages induce apoptosis in proximal tubule cells.Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivoEssential versus accessory aspects of cell death: recommendations of the NCCD 2015.Proteomic screening of salt-stress-induced changes in plasma membranes of Synechocystis sp. strain PCC 6803.Cellular stress responses: cell survival and cell deathPretubulysin: a new option for the treatment of metastatic cancer.Cell stress and cell death.NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexesTargeting mitochondria for cancer therapy.Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomasMolecular mechanisms of sulfasalazine-induced T-cell apoptosisSequential dosing in chemosensitization: targeting the PI3K/Akt/mTOR pathway in neuroblastoma.Apoptosis in hematological disorders.Death receptor signaling in cancer therapy.Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acidApoptosis pathways in neuroblastoma therapy.A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases.Modulation of TRAIL signaling for cancer therapy.Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response.Signaling through death receptors in cancer therapy.Receptor proteins in selective autophagy.Targeting apoptosis pathways in cancer therapy.Exploiting death receptor signaling pathways for tumor therapy.
P50
Q22676705-FCFB90C1-FDC0-4708-8060-17B6B8CE7386Q24294685-1FC44274-D329-491D-8A94-1A3E6B2764B3Q24297120-C445A7AC-F736-4BCB-A72B-9C48D87E07A4Q24298796-61568324-8E96-4EC1-B5CE-4EFACCBBD58AQ24299986-96766F79-891C-4324-B7E3-2E3857EC3913Q24300558-0EECC7F8-20C5-4F21-9B32-DB906EA21377Q24302531-6B0A87B8-9E4C-4FDD-A37C-78486517D254Q24319961-66A7F03D-D911-4816-95AE-4B88FD7C2A9CQ27005878-3BED7C51-BBEC-4C0C-9114-8B07A318C092Q28081403-34295380-C6C4-4E0F-9D05-C6227417D2C4Q28253275-B4DB53A0-23B4-40E8-98A1-38F1B9C4FCDDQ28273774-F427C456-FF5E-4FC4-AC4E-E2B4F934562BQ28283859-B61D3111-2155-4F38-BC1A-57581574E2E6Q28484680-4A840081-467A-4F24-857C-496A99F2C23CQ28591258-2AAF7296-3BA5-45DA-9217-3678CC5CDB44Q29616161-0B08B59B-E217-44FD-8C8B-79DDCE751A9CQ30310775-0607C795-8385-4D13-AD08-42CD260BB546Q30316789-2BBBE12A-2EEE-46BB-8C4F-7F0176A6355BQ30408769-448EB982-748A-42CC-A255-68DA2739FC3DQ33231142-D552883B-A492-4F1E-83C2-3C8C3D28487DQ33674213-14ECEEEF-7A12-48ED-9862-E96486B70E92Q33695171-3B35A9B0-B91F-4461-9355-DD8EDBCAEC7EQ33746751-828B3034-C70B-4C26-AA6D-03DC957F390CQ34015940-AF81F5CC-E6D8-4EF0-A153-55AB9824E934Q34115304-393C6ACC-811C-4E51-99A8-7FDBB11FF338Q34517339-30758A1B-EA01-4752-A94C-8EA846A90450Q35044669-5D9DCD75-1C8D-4136-8951-A202C04763A3Q35082400-08C0AE4A-CD08-436E-AB9F-927393C17458Q35091131-BEB83245-7E98-4012-AFAB-1ECBE397C83BQ35137781-4F33D7A1-39BE-440C-878A-D80E5306FFD5Q35152103-D5B0BDAF-010B-4B43-8621-79E8C7F500ABQ35184965-953D6460-0696-4F93-A18B-135067F59AA0Q35277921-AC94CD24-96DB-4EB3-BD4B-56ED1954910BQ35561650-7CD54748-E821-42E4-BC3F-BA721A2FB1C4Q35756898-268A8962-5301-4E80-B643-D054E93C3978Q35832054-A588702E-883F-4C6C-A199-81D965B94FBAQ35834885-ECAAC4E6-26BB-408A-A68F-1BE096A5D2A5Q35872411-896A1559-420C-4147-9D2C-D9D2FC5ED764Q35971851-8C90F264-F5DE-4630-ADAB-C5FB80B91780Q35976606-BA659EB8-2BAC-4E23-9423-6BD407EFA10D
P50
description
deutsche Kinderonkologin und Hochschullehrerin
@de
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Simone Fulda
@ast
Simone Fulda
@de
Simone Fulda
@en
Simone Fulda
@es
Simone Fulda
@nl
Simone Fulda
@sl
type
label
Simone Fulda
@ast
Simone Fulda
@de
Simone Fulda
@en
Simone Fulda
@es
Simone Fulda
@nl
Simone Fulda
@sl
prefLabel
Simone Fulda
@ast
Simone Fulda
@de
Simone Fulda
@en
Simone Fulda
@es
Simone Fulda
@nl
Simone Fulda
@sl
P214
P227
P244
P106
P19
P2080
P21
P213
0000 0000 5129 8741
P214
P227
P244
nb2006005747
P2798
P31
P3762
P496
0000-0002-0459-6417
P569
1968-01-01T00:00:00Z
P734
P735
P7859
lccn-nb2006005747